Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice

Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice

Virological success (VS) and immunological reconstitution (IR) of antiretroviral-naive HIV-1-infected patients with pre-therapy viral load (VL) >500,000 copies/ml was assessed after 12 months of treatment according to initial drug-class regimens. An observational multicentre retrospective study w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antiviral therapy 2018-01, Vol.23 (3), p.249-257
Hauptverfasser: Santoro, Maria Mercedes, Di Carlo, Domenico, Armenia, Daniele, Zaccarelli, Mauro, Pinnetti, Carmela, Colafigli, Manuela, Prati, Francesca, Boschi, Andrea, Antoni, Anna Maria Degli, Lagi, Filippo, Sighinolfi, Laura, Gervasoni, Cristina, Andreoni, Massimo, Antinori, Andrea, Mussini, Cristina, Perno, Carlo Federico, Borghi, Vanni, Sterrantino, Gaetana
Format: Artikel
Sprache:eng
Schlagworte:
Acquired immune deficiency syndrome
AIDS
Antiretroviral drugs
CD4 antigen
HIV
Human immunodeficiency virus
Immune response
Immunology
Integrase
Lymphocytes T
Non-nucleoside reverse transcriptase inhibitors
Nucleoside reverse transcriptase inhibitors
Patients
Protease inhibitors
Proteinase inhibitors
RNA-directed DNA polymerase
Survival analysis
Viremia
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Virological success (VS) and immunological reconstitution (IR) of antiretroviral-naive HIV-1-infected patients with pre-therapy viral load (VL) >500,000 copies/ml was assessed after 12 months of treatment according to initial drug-class regimens. An observational multicentre retrospective study was performed. VS was defined as the first VL
ISSN:1359-6535
2040-2058
DOI:10.3851/IMP3197